Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease

Payal C. Desai, Allison M. Deal, Emily R. Pfaff, Bahjat Qaqish, Leyna M. Hebden, Yara A. Park, Kenneth Ataga

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Red blood cell (RBC) alloimmunization is a significant clinical complication of sickle cell disease (SCD). It can lead to difficulty with cross-matching for future transfusions and may sometimes trigger life-threatening delayed hemolytic transfusion reactions. We conducted a retrospective study to explore the association of clinical complications and age of RBC with alloimmunization in patients with SCD followed at a single institution from 2005 to 2012. One hundred and sixty six patients with a total of 488 RBC transfusions were evaluated. Nineteen patients (11%) developed new alloantibodies following blood transfusions during the period of review. The median age of RBC units was 20 days (interquartile range: 14-27 days). RBC antibody formation was significantly associated with the age of RBC units (P=0.002), with a hazard ratio of 3.5 (95% CI: 1.71-7.11) for a RBC unit that was 7 days old and 9.8 (95% CI: 2.66-35.97) for a unit that was 35 days old, 28 days after the blood transfusion. No association was observed between RBC alloimmunization and acute vaso-occlusive complications. Although increased echocardiography-derived tricuspid regurgitant jet velocity (TRV) was associated with the presence of RBC alloantibodies (P=0.02), TRV was not significantly associated with alloimmunization when adjusted for patient age and number of transfused RBC units. Our study suggests that RBC antibody formation is significantly associated with older age of RBCs at the time of transfusion. Prospective studies in patients with SCD are required to confirm this finding.

Original languageEnglish (US)
Pages (from-to)691-695
Number of pages5
JournalAmerican Journal of Hematology
Volume90
Issue number8
DOIs
StatePublished - Aug 1 2015

Fingerprint

Sickle Cell Anemia
Erythrocytes
Isoantibodies
Blood Transfusion
Antibody Formation
Erythrocyte Transfusion
Echocardiography
Retrospective Studies
Prospective Studies

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease. / Desai, Payal C.; Deal, Allison M.; Pfaff, Emily R.; Qaqish, Bahjat; Hebden, Leyna M.; Park, Yara A.; Ataga, Kenneth.

In: American Journal of Hematology, Vol. 90, No. 8, 01.08.2015, p. 691-695.

Research output: Contribution to journalArticle

Desai, Payal C. ; Deal, Allison M. ; Pfaff, Emily R. ; Qaqish, Bahjat ; Hebden, Leyna M. ; Park, Yara A. ; Ataga, Kenneth. / Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease. In: American Journal of Hematology. 2015 ; Vol. 90, No. 8. pp. 691-695.
@article{516f18a835eb43a99cf984c97c86a84c,
title = "Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease",
abstract = "Red blood cell (RBC) alloimmunization is a significant clinical complication of sickle cell disease (SCD). It can lead to difficulty with cross-matching for future transfusions and may sometimes trigger life-threatening delayed hemolytic transfusion reactions. We conducted a retrospective study to explore the association of clinical complications and age of RBC with alloimmunization in patients with SCD followed at a single institution from 2005 to 2012. One hundred and sixty six patients with a total of 488 RBC transfusions were evaluated. Nineteen patients (11{\%}) developed new alloantibodies following blood transfusions during the period of review. The median age of RBC units was 20 days (interquartile range: 14-27 days). RBC antibody formation was significantly associated with the age of RBC units (P=0.002), with a hazard ratio of 3.5 (95{\%} CI: 1.71-7.11) for a RBC unit that was 7 days old and 9.8 (95{\%} CI: 2.66-35.97) for a unit that was 35 days old, 28 days after the blood transfusion. No association was observed between RBC alloimmunization and acute vaso-occlusive complications. Although increased echocardiography-derived tricuspid regurgitant jet velocity (TRV) was associated with the presence of RBC alloantibodies (P=0.02), TRV was not significantly associated with alloimmunization when adjusted for patient age and number of transfused RBC units. Our study suggests that RBC antibody formation is significantly associated with older age of RBCs at the time of transfusion. Prospective studies in patients with SCD are required to confirm this finding.",
author = "Desai, {Payal C.} and Deal, {Allison M.} and Pfaff, {Emily R.} and Bahjat Qaqish and Hebden, {Leyna M.} and Park, {Yara A.} and Kenneth Ataga",
year = "2015",
month = "8",
day = "1",
doi = "10.1002/ajh.24051",
language = "English (US)",
volume = "90",
pages = "691--695",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease

AU - Desai, Payal C.

AU - Deal, Allison M.

AU - Pfaff, Emily R.

AU - Qaqish, Bahjat

AU - Hebden, Leyna M.

AU - Park, Yara A.

AU - Ataga, Kenneth

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Red blood cell (RBC) alloimmunization is a significant clinical complication of sickle cell disease (SCD). It can lead to difficulty with cross-matching for future transfusions and may sometimes trigger life-threatening delayed hemolytic transfusion reactions. We conducted a retrospective study to explore the association of clinical complications and age of RBC with alloimmunization in patients with SCD followed at a single institution from 2005 to 2012. One hundred and sixty six patients with a total of 488 RBC transfusions were evaluated. Nineteen patients (11%) developed new alloantibodies following blood transfusions during the period of review. The median age of RBC units was 20 days (interquartile range: 14-27 days). RBC antibody formation was significantly associated with the age of RBC units (P=0.002), with a hazard ratio of 3.5 (95% CI: 1.71-7.11) for a RBC unit that was 7 days old and 9.8 (95% CI: 2.66-35.97) for a unit that was 35 days old, 28 days after the blood transfusion. No association was observed between RBC alloimmunization and acute vaso-occlusive complications. Although increased echocardiography-derived tricuspid regurgitant jet velocity (TRV) was associated with the presence of RBC alloantibodies (P=0.02), TRV was not significantly associated with alloimmunization when adjusted for patient age and number of transfused RBC units. Our study suggests that RBC antibody formation is significantly associated with older age of RBCs at the time of transfusion. Prospective studies in patients with SCD are required to confirm this finding.

AB - Red blood cell (RBC) alloimmunization is a significant clinical complication of sickle cell disease (SCD). It can lead to difficulty with cross-matching for future transfusions and may sometimes trigger life-threatening delayed hemolytic transfusion reactions. We conducted a retrospective study to explore the association of clinical complications and age of RBC with alloimmunization in patients with SCD followed at a single institution from 2005 to 2012. One hundred and sixty six patients with a total of 488 RBC transfusions were evaluated. Nineteen patients (11%) developed new alloantibodies following blood transfusions during the period of review. The median age of RBC units was 20 days (interquartile range: 14-27 days). RBC antibody formation was significantly associated with the age of RBC units (P=0.002), with a hazard ratio of 3.5 (95% CI: 1.71-7.11) for a RBC unit that was 7 days old and 9.8 (95% CI: 2.66-35.97) for a unit that was 35 days old, 28 days after the blood transfusion. No association was observed between RBC alloimmunization and acute vaso-occlusive complications. Although increased echocardiography-derived tricuspid regurgitant jet velocity (TRV) was associated with the presence of RBC alloantibodies (P=0.02), TRV was not significantly associated with alloimmunization when adjusted for patient age and number of transfused RBC units. Our study suggests that RBC antibody formation is significantly associated with older age of RBCs at the time of transfusion. Prospective studies in patients with SCD are required to confirm this finding.

UR - http://www.scopus.com/inward/record.url?scp=84937516742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937516742&partnerID=8YFLogxK

U2 - 10.1002/ajh.24051

DO - 10.1002/ajh.24051

M3 - Article

VL - 90

SP - 691

EP - 695

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 8

ER -